Table 3.
Blood and urinary electrolytes concentrations in experimental groups
| Group | sNa | sK | sCl | sCr | UV | UNaV | CNa | FENa | UaldV | UKV | CK |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Salt solution | 145.3 ± 0.9 | 4.05 ± 0.23 | 102.0 ± 0.8 | 0.21 ± 0.01 | 6.68 ± 5.55 | 1.77 ± 0.85 | 12.2 ± 5.8 | 1.50 ± 0.46 | 8.42 ± 4.76 | 9.55 ± 2.72 | 234 ± 59 |
| Nenrin | 144.7 ± 0.8 | 4.08 ± 0.27 | 101.7 ± 0.6 | 0.21 ± 0.01 | 7.96 ± 3.77 | 2.27 ± 0.58* | 15.7 ± 4.0 | 1.38 ± 0.28 | 9.76 ± 3.14 | 12.5 ± 3.17 | 312 ± 88* |
| Shinki | 145.0 ± 1.1 | 4.08 ± 0.21 | 102.0 ± 1.2 | 0.21 ± 0.02 | 7.22 ± 4.48 | 1.90 ± 0.55 | 13.1 ± 3.8 | 1.44 ± 1.02 | 9.12 ± 3.42 | 9.12 ± 4.02** | 225 ± 101** |
Salt solution, group given salt solution; nenrin, Marukome Nenrin group; and shinki, Marukome shinki miso rich in ACE inhibitory activity miso group. Values are expressed as means ± SD (n = 10 in each group). Differences were assessed by one-way analysis of variance (ANOVA) followed by Fisher’s least significant difference post-hoc test (LSD test)
sNa serum sodium concentrations, sK serum potassium concentrations, sCl serum chloride concentrations, sCr serum creatinine concentrations, UV urine volume (mL/100 gBW/day), UNaV urinary excretions of sodium (mEq/100 gBW/day), CNa sodium clearance (mL/100 gBW/day), FENa fractional excretion of sodium (%), UaldV urinary excretions of aldosterone (ng/day), UKV urinary excretions of potassium (mEq/100 gBW/day), CK potassium clearance (mL/100 gBW/day
*P < 0.05 vs salt solution group, **P < 0.05 vs nenrin miso group